Thrivent Financial For Lutherans Neogenomics Inc Transaction History

Thrivent Financial For Lutherans

$52.6 Billion
Q3 2024

A detailed history of Thrivent Financial For Lutherans transactions in Neogenomics Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 100,641 shares of NEO stock, worth $1.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100,641

Previous 106,020 5.07%

Holding current value

$1.66 Million

Previous $1.47 Million 0.95%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$13.4 - $17.73 $72,078 - $95,369	-5,379 Reduced 5.07%	100,641 $1.48 Million
Q2 2024 Aug 13, 2024	SELL	$13.01 - $15.77 $59,312 - $71,895	-4,559 Reduced 4.12%	106,020 $1.47 Million
Q1 2024 May 14, 2024	SELL	$14.06 - $16.79 $42,222 - $50,420	-3,003 Reduced 2.64%	110,579 $1.74 Million
Q4 2023 Feb 14, 2024	SELL	$11.67 - $20.73 $36,480 - $64,801	-3,126 Reduced 2.68%	113,582 $1.84 Million
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $64,844 - $95,265	-5,337 Reduced 4.37%	116,708 $1.44 Million
Q2 2023 Aug 14, 2023	SELL	$14.1 - $19.83 $44,034 - $61,929	-3,123 Reduced 2.5%	122,045 $1.96 Million
Q1 2023 May 17, 2023	SELL	$9.09 - $19.45 $39,877 - $85,327	-4,387 Reduced 3.39%	125,168 $2.18 Million
Q4 2022 Feb 08, 2023	SELL	$6.45 - $12.07 $3,108 - $5,817	-482 Reduced 0.37%	129,555 $1.2 Million
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $611,806 - $1 Million	-77,838 Reduced 37.44%	130,037 $1.12 Million
Q2 2022 Aug 16, 2022	BUY	$7.06 - $13.97 $759,973 - $1.5 Million	107,645 Added 107.4%	207,875 $1.7 Million
Q1 2022 May 13, 2022	BUY	$12.15 - $35.28 $388 - $1,128	32 Added 0.03%	100,230 $1.22 Million
Q4 2021 Feb 16, 2022	BUY	$30.49 - $48.49 $28,203 - $44,853	925 Added 0.93%	100,198 $3.42 Million
Q3 2021 Nov 15, 2021	BUY	$41.66 - $52.52 $119,480 - $150,627	2,868 Added 2.97%	99,273 $4.79 Million
Q2 2021 Aug 19, 2021	BUY	$36.62 - $51.69 $12,560 - $17,729	343 Added 0.36%	96,405 $4.36 Million
Q1 2021 May 17, 2021	BUY	$41.56 - $59.88 $172,889 - $249,100	4,160 Added 4.53%	96,062 $4.63 Million
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $12,050 - $18,860	334 Added 0.36%	91,902 $4.95 Million
Q3 2020 Nov 10, 2020	SELL	$33.26 - $40.48 $11,075 - $13,479	-333 Reduced 0.36%	91,568 $3.38 Million
Q2 2020 Aug 12, 2020	BUY	$24.21 - $31.02 $106,475 - $136,425	4,398 Added 5.03%	91,901 $2.85 Million
Q1 2020 May 15, 2020	BUY	$20.5 - $34.53 $89,544 - $150,827	4,368 Added 5.25%	87,503 $2.42 Million
Q4 2019 Feb 13, 2020	BUY	$18.96 - $29.84 $11,641 - $18,321	614 Added 0.74%	83,135 $2.43 Million
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $47,723 - $65,495	2,496 Added 3.12%	82,521 $1.58 Million
Q2 2019 Aug 13, 2019	BUY	$19.57 - $24.1 $174,877 - $215,357	8,936 Added 12.57%	80,025 $1.76 Million
Q1 2019 May 14, 2019	BUY	$12.14 - $20.46 $863,020 - $1.45 Million	71,089 New	71,089 $1.45 Million

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.07B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Neogenomics Inc Transaction History